People: Idorsia Ltd (IDIA.S)
16 Aug 2019
Dr. Jean-Pierre (JP) Garnier, Ph.D., is Non-Executive Independent Chairman of the Board of Idorsia Ltd. He holds Various management positions at ScheringPlough. Within SmithKline Beecham, President of the pharmaceutical business in North America (1990), elected to the Board of Directors (1992), Chairman, Pharmaceuticals (from 1994), Chief Operating Officer (COO) (from 1995) and Chief Executive Officer (CEO) (from April 2000). First CEO of GlaxoSmithKline, 2001–2008. CEO of Laboratoires Pierre Fabre, 2008–2010. He is a Member of the Board of Directors of three listed companies, United Technologies Corporation, Radius Health, Inc., Carmat SA (Chairman) and former Chairman of one unlisted company, Alzheon, Inc. (until August 2018). Operating Partner of the unlisted company Advent International Corporation. Member of the Advisory Board of Newman’s Own Foundation. Officer of the Legion of Honour and Knight Commander of the Order of the British Empire. He holds MSc in Pharmaceutical Science and PhD in Pharmacology from Louis Pasteur University, Strasbourg, France; MBA from Stanford University, California, US.
|Total Annual Compensation, CHF||65,625|
|Restricted Stock Award, CHF||--|
|Long-Term Incentive Plans, CHF||--|
|All Other, CHF||190,954|
|Fiscal Year Total, CHF||256,579|